Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0be40d5a07-trace').style.display = (document.getElementById('cakeErr67f0be40d5a07-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f0be40d5a07-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0be40d5a07-code').style.display = (document.getElementById('cakeErr67f0be40d5a07-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0be40d5a07-context').style.display = (document.getElementById('cakeErr67f0be40d5a07-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f0be40d5a07-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f0be40d5a07-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26745,
		&#039;title&#039; =&gt; &#039;After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The authority on Friday included 52 new drug formulation packs under its price control mechanism.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 13 December, 2014, http://timesofindia.indiatimes.com/india/After-price-control-several-key-drugs-in-short-supply/articleshow/45499903.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674787,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26745,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The authority on Friday included 52 new drug formulation packs under its price control mechanism.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26745,
	&#039;title&#039; =&gt; &#039;After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The authority on Friday included 52 new drug formulation packs under its price control mechanism.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 13 December, 2014, http://timesofindia.indiatimes.com/india/After-price-control-several-key-drugs-in-short-supply/articleshow/45499903.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674787,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26745
$metaTitle = &#039;LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The authority on Friday included 52 new drug formulation packs under its price control mechanism.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp; Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>After price control, several key drugs in short supply -Durgesh Nandan Jha &amp; Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.</p><p align="justify">Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.</p><p align="justify">Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.</p><p align="justify">Kailash Gupta, president of All India Chemists and Distributor's Federation, said several vital medicines went into short supply right after their prices were controlled by the government.</p><p align="justify">&quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid's price was cut by nearly Rs 30 for a sachet containing 15 tablets,&quot; said Gupta.</p><p align="justify">&quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&quot; he said.</p><p align="justify">According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &quot;The substitutes available in the market for this medicine are costlier,&quot; he said.</p><p align="justify">Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital's pharmacy.</p><p align="justify">The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&quot; The spokesperson added that restoring normal supply may take a few months.</p><p align="justify">A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&quot; a senior executive of the company said.</p><p align="justify">National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.</p><p align="justify">The authority on Friday included 52 new drug formulation packs under its price control mechanism.</p><p align="justify">According to IMS Health's latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.</p><p align="justify">Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; a senior executive from a leading drug manufacturer said.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0be40d5a07-trace').style.display = (document.getElementById('cakeErr67f0be40d5a07-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f0be40d5a07-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0be40d5a07-code').style.display = (document.getElementById('cakeErr67f0be40d5a07-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0be40d5a07-context').style.display = (document.getElementById('cakeErr67f0be40d5a07-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f0be40d5a07-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f0be40d5a07-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26745,
		&#039;title&#039; =&gt; &#039;After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The authority on Friday included 52 new drug formulation packs under its price control mechanism.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 13 December, 2014, http://timesofindia.indiatimes.com/india/After-price-control-several-key-drugs-in-short-supply/articleshow/45499903.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674787,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26745,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The authority on Friday included 52 new drug formulation packs under its price control mechanism.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26745,
	&#039;title&#039; =&gt; &#039;After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The authority on Friday included 52 new drug formulation packs under its price control mechanism.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 13 December, 2014, http://timesofindia.indiatimes.com/india/After-price-control-several-key-drugs-in-short-supply/articleshow/45499903.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674787,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26745
$metaTitle = &#039;LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The authority on Friday included 52 new drug formulation packs under its price control mechanism.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp; Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>After price control, several key drugs in short supply -Durgesh Nandan Jha &amp; Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.</p><p align="justify">Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.</p><p align="justify">Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.</p><p align="justify">Kailash Gupta, president of All India Chemists and Distributor's Federation, said several vital medicines went into short supply right after their prices were controlled by the government.</p><p align="justify">&quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid's price was cut by nearly Rs 30 for a sachet containing 15 tablets,&quot; said Gupta.</p><p align="justify">&quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&quot; he said.</p><p align="justify">According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &quot;The substitutes available in the market for this medicine are costlier,&quot; he said.</p><p align="justify">Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital's pharmacy.</p><p align="justify">The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&quot; The spokesperson added that restoring normal supply may take a few months.</p><p align="justify">A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&quot; a senior executive of the company said.</p><p align="justify">National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.</p><p align="justify">The authority on Friday included 52 new drug formulation packs under its price control mechanism.</p><p align="justify">According to IMS Health's latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.</p><p align="justify">Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; a senior executive from a leading drug manufacturer said.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0be40d5a07-trace').style.display = (document.getElementById('cakeErr67f0be40d5a07-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f0be40d5a07-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0be40d5a07-code').style.display = (document.getElementById('cakeErr67f0be40d5a07-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0be40d5a07-context').style.display = (document.getElementById('cakeErr67f0be40d5a07-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f0be40d5a07-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f0be40d5a07-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26745,
		&#039;title&#039; =&gt; &#039;After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The authority on Friday included 52 new drug formulation packs under its price control mechanism.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 13 December, 2014, http://timesofindia.indiatimes.com/india/After-price-control-several-key-drugs-in-short-supply/articleshow/45499903.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674787,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26745,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The authority on Friday included 52 new drug formulation packs under its price control mechanism.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26745,
	&#039;title&#039; =&gt; &#039;After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The authority on Friday included 52 new drug formulation packs under its price control mechanism.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 13 December, 2014, http://timesofindia.indiatimes.com/india/After-price-control-several-key-drugs-in-short-supply/articleshow/45499903.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674787,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26745
$metaTitle = &#039;LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp;amp; Sushmi Dey&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The government&#039;s price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Kailash Gupta, president of All India Chemists and Distributor&#039;s Federation, said several vital medicines went into short supply right after their prices were controlled by the government.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid&#039;s price was cut by nearly Rs 30 for a sachet containing 15 tablets,&amp;quot; said Gupta.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &amp;quot;The substitutes available in the market for this medicine are costlier,&amp;quot; he said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital&#039;s pharmacy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &amp;quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&amp;quot; The spokesperson added that restoring normal supply may take a few months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &amp;quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&amp;quot; a senior executive of the company said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The authority on Friday included 52 new drug formulation packs under its price control mechanism.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to IMS Health&#039;s latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &amp;quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; a senior executive from a leading drug manufacturer said.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp; Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>After price control, several key drugs in short supply -Durgesh Nandan Jha &amp; Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.</p><p align="justify">Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.</p><p align="justify">Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.</p><p align="justify">Kailash Gupta, president of All India Chemists and Distributor's Federation, said several vital medicines went into short supply right after their prices were controlled by the government.</p><p align="justify">&quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid's price was cut by nearly Rs 30 for a sachet containing 15 tablets,&quot; said Gupta.</p><p align="justify">&quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&quot; he said.</p><p align="justify">According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &quot;The substitutes available in the market for this medicine are costlier,&quot; he said.</p><p align="justify">Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital's pharmacy.</p><p align="justify">The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&quot; The spokesperson added that restoring normal supply may take a few months.</p><p align="justify">A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&quot; a senior executive of the company said.</p><p align="justify">National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.</p><p align="justify">The authority on Friday included 52 new drug formulation packs under its price control mechanism.</p><p align="justify">According to IMS Health's latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.</p><p align="justify">Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; a senior executive from a leading drug manufacturer said.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 26745,
		'title' => 'After price control, several key drugs in short supply -Durgesh Nandan Jha & Sushmi Dey',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<em>NEW DELHI: </em>The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.
</p>
<p align="justify">
Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.
</p>
<p align="justify">
Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.
</p>
<p align="justify">
Kailash Gupta, president of All India Chemists and Distributor's Federation, said several vital medicines went into short supply right after their prices were controlled by the government.
</p>
<p align="justify">
&quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid's price was cut by nearly Rs 30 for a sachet containing 15 tablets,&quot; said Gupta.
</p>
<p align="justify">
&quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&quot; he said.
</p>
<p align="justify">
According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &quot;The substitutes available in the market for this medicine are costlier,&quot; he said.
</p>
<p align="justify">
Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital's pharmacy.
</p>
<p align="justify">
The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&quot; The spokesperson added that restoring normal supply may take a few months.
</p>
<p align="justify">
A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&quot; a senior executive of the company said.
</p>
<p align="justify">
National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.
</p>
<p align="justify">
The authority on Friday included 52 new drug formulation packs under its price control mechanism.
</p>
<p align="justify">
According to IMS Health's latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.
</p>
<p align="justify">
Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; a senior executive from a leading drug manufacturer said.
</p>',
		'credit_writer' => 'The Times of India, 13 December, 2014, http://timesofindia.indiatimes.com/india/After-price-control-several-key-drugs-in-short-supply/articleshow/45499903.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4674787,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 26745,
	'metaTitle' => 'LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp; Sushmi Dey',
	'metaKeywords' => 'National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines',
	'metaDesc' => '
-The Times of India


NEW DELHI: The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are...',
	'disp' => '<div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.</p><p align="justify">Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.</p><p align="justify">Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.</p><p align="justify">Kailash Gupta, president of All India Chemists and Distributor's Federation, said several vital medicines went into short supply right after their prices were controlled by the government.</p><p align="justify">&quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid's price was cut by nearly Rs 30 for a sachet containing 15 tablets,&quot; said Gupta.</p><p align="justify">&quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&quot; he said.</p><p align="justify">According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &quot;The substitutes available in the market for this medicine are costlier,&quot; he said.</p><p align="justify">Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital's pharmacy.</p><p align="justify">The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&quot; The spokesperson added that restoring normal supply may take a few months.</p><p align="justify">A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&quot; a senior executive of the company said.</p><p align="justify">National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.</p><p align="justify">The authority on Friday included 52 new drug formulation packs under its price control mechanism.</p><p align="justify">According to IMS Health's latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.</p><p align="justify">Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; a senior executive from a leading drug manufacturer said.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 26745,
	'title' => 'After price control, several key drugs in short supply -Durgesh Nandan Jha &amp; Sushmi Dey',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<em>NEW DELHI: </em>The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.
</p>
<p align="justify">
Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.
</p>
<p align="justify">
Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.
</p>
<p align="justify">
Kailash Gupta, president of All India Chemists and Distributor's Federation, said several vital medicines went into short supply right after their prices were controlled by the government.
</p>
<p align="justify">
&quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid's price was cut by nearly Rs 30 for a sachet containing 15 tablets,&quot; said Gupta.
</p>
<p align="justify">
&quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&quot; he said.
</p>
<p align="justify">
According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &quot;The substitutes available in the market for this medicine are costlier,&quot; he said.
</p>
<p align="justify">
Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital's pharmacy.
</p>
<p align="justify">
The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&quot; The spokesperson added that restoring normal supply may take a few months.
</p>
<p align="justify">
A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&quot; a senior executive of the company said.
</p>
<p align="justify">
National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.
</p>
<p align="justify">
The authority on Friday included 52 new drug formulation packs under its price control mechanism.
</p>
<p align="justify">
According to IMS Health's latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.
</p>
<p align="justify">
Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; a senior executive from a leading drug manufacturer said.
</p>',
	'credit_writer' => 'The Times of India, 13 December, 2014, http://timesofindia.indiatimes.com/india/After-price-control-several-key-drugs-in-short-supply/articleshow/45499903.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'after-price-control-several-key-drugs-in-short-supply-durgesh-nandan-jha-sushmi-dey-4674787',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4674787,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 26745
$metaTitle = 'LATEST NEWS UPDATES | After price control, several key drugs in short supply -Durgesh Nandan Jha &amp; Sushmi Dey'
$metaKeywords = 'National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines'
$metaDesc = '
-The Times of India


NEW DELHI: The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are...'
$disp = '<div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops.</p><p align="justify">Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now.</p><p align="justify">Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply.</p><p align="justify">Kailash Gupta, president of All India Chemists and Distributor's Federation, said several vital medicines went into short supply right after their prices were controlled by the government.</p><p align="justify">&quot;Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid's price was cut by nearly Rs 30 for a sachet containing 15 tablets,&quot; said Gupta.</p><p align="justify">&quot;We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines,&quot; he said.</p><p align="justify">According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. &quot;The substitutes available in the market for this medicine are costlier,&quot; he said.</p><p align="justify">Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital's pharmacy.</p><p align="justify">The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: &quot;We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible.&quot; The spokesperson added that restoring normal supply may take a few months.</p><p align="justify">A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. &quot;We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints,&quot; a senior executive of the company said.</p><p align="justify">National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month.</p><p align="justify">The authority on Friday included 52 new drug formulation packs under its price control mechanism.</p><p align="justify">According to IMS Health's latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually.</p><p align="justify">Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. &quot;NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; a senior executive from a leading drug manufacturer said.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

After price control, several key drugs in short supply -Durgesh Nandan Jha & Sushmi Dey

-The Times of India NEW DELHI: The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops. Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others. Albumin, a lifesaving protein, has been in short supply for nearly four months now. Druggists claim the pharmaceutical companies have reduced the production of these vital drugs because their profit margins have gone down - a charge denied by manufacturers. Kailash Gupta, head of a federation of chemists, said while controlling the price of essential medicines the government should also ensure their regular supply. Kailash Gupta, president of All India Chemists and Distributor's Federation, said several vital medicines went into short supply right after their prices were controlled by the government. "Ten capsules of Zyloric used to cost Rs 37.40. But after price control measures announced by the government, it now costs Rs 23.30. Similarly, the MRP of Eltroxin (25mg) went down from Rs 76 to Rs 69. Ocid's price was cut by nearly Rs 30 for a sachet containing 15 tablets," said Gupta. "We get many patients who are suffering from chronic ailments and dependent on some of these medicines. They are desperate to get these medicines," he said. According to Dr Anoop Misra, chairman, Fortis-CDOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Zyloric is one of the standard drugs prescribed to kidney patients, those suffering from gout and even diabetics to control uric acid. "The substitutes available in the market for this medicine are costlier," he said. Dr Sujeet Jha, head of the endocrinology department at Max hospital, Saket also confirmed the absence of Zyloric at the hospital's pharmacy. The spokesperson of GlaxoSmithKline, which manufactures the drug, told TOI: "We are currently facing some issues across our manufacturing network that is impacting our ability to supply a number of products. We are doing our utmost to bring supply back to normal as soon as possible." The spokesperson added that restoring normal supply may take a few months. A senior official from Cadila Healthcare said there was no shortage of any drug manufactured by the company. "We continue to produce at our previous levels. There is no cut in either production or supply. I am surprised to hear that you have found shortage. From our end, the supply situation is fine and we have not received any complaints," a senior executive of the company said. National Pharmaceutical Pricing Authority (NPPA), which has the mandate to ensure availability of medicines in the market while keeping a check on prices, said it had not received any complaints on shortages due to price control. A senior official in the authority said there was no question of price regulation leading to drug shortages because the domestic industry has been witnessing growth in its annual turnover every month. The authority on Friday included 52 new drug formulation packs under its price control mechanism. According to IMS Health's latest market data, pharmaceutical sales in the domestic market during November grew 11.6% from the previous month. However, it shows sales of price-regulated medicines had come down marginally by 1.8% as compared to previous year. The total pharmaceutical market is pegged at over Rs 86,000 crore annually. Industry officials say the growth of the sector is hindered because of overregulation and lack of clarity in pricing norms. "NPPA should regulate prices as per the pricing policy. Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per established criteria. The role of NPPA is to implement the policy in letter and spirit and not create confusion leading to instability," a senior executive from a leading drug manufacturer said.